Latest round: IPO. Rajeev Singh is the CEO of Accolade, a personalized medicine and health advocacy company that went public in July 2020.
Rajeev Singh is the CEO of Accolade, a personalized medicine and health advocacy company that went public in July 2020. Prior to Accolade, he co-founded Concur in 1993, a company specializing in corporate expense and travel solutions, which was later sold to SAP for over $8 billion in 2014. He joined Accolade two years after the Concur acquisition.
Full founder directory · Investor directory · Company funding database · Fundraising library